Fenbid that ibuprofen extended-release capsules, ibuprofen extended-release capsules and celecoxib belongs to the non-steroidal anti-inflammatory drugs, the two drugs do not exist in the comparison of who has fewer side effects than who, because of the individual differences, so do not have comparability. Lofen extended-release capsules and celecoxib are non-steroidal anti-inflammatory drugs, the mechanism of action of the drug is more or less the same, there is an inhibition of cyclooxygenase, the difference is that in addition to the inhibition of cyclooxygenase-2 capsules on cyclooxygenase-1 than the stronger inhibition of celecoxib, and therefore Lofen extended-release capsules relative to celecoxib on the gastrointestinal tract to produce side effects is relatively greater. However, celecoxib has a greater cardiovascular risk than lovenoxib extended-release capsules, so the two drugs are not comparable, and there are differences between individuals who take the drugs, so the two drugs are not comparable. The choice of drug should be decided by a medical professional according to the patient’s condition, for example, celecoxib is more effective for joint pain caused by a variety of factors, and ibuprofen extended-release capsules are more effective for fever and pain caused by a variety of factors, so the final choice of drug should not be considered only for the side effects of the drug. Both ibuprofen extended-release capsules and celecoxib may have gastrointestinal side effects such as nausea and vomiting. They are contraindicated in people who are allergic to NSAIDs. Note that these two medications are not recommended to be used together, nor are they recommended to be taken orally for a long period of time to control symptoms. The medication should be taken under the supervision of a physician, and it is recommended that patients who need to take ibuprofen or celecoxib consult the relevant departments of a regular hospital, rather than taking the medication on their own.